Five- to fifteen-year follow-up after Fontan operation

David J. Driscoll, Kenneth P. Offord, Robert H. Feldt, Hartzell V Schaff, Francisco J. Puga, Gordon K. Danielson

Research output: Contribution to journalArticle

432 Citations (Scopus)

Abstract

Background. The purpose of this study was to estimate survival and quality of outcome and assess factors associated with outcome for patients out 5 to 15 years from their Fontan operation. Methods and Results. We studied 352 patients who had the Fontan operation prior to 1985. The overall 1-, 5-, and 10-year survival was 77%, 70%, and 60%, respectively. The following factors were significantly associated with lower survival: univentricular heart or complex congenital anomalies other than tricuspid atresia, early calendar year of operation, heterotaxia syndromes, early age at operation, increased pulmonary artery pressure, atrioventricular valve dysfunction, and higher (worse) New York Heart Association class; Reoperations were necessary for 103 of the 352 patients. At least 20% of the survivors have or have had cardiac arrhythmias requiring antiarrhythmic medication or mechanical pacemaker insertion. Between 7% and 10% of the patients have had or had protein-losing enteropathy/hypoproteinemia. At 5 years postoperatively, 122 patients (34.7%) were alive with a better New York Heart Association functional classification than preoperativeiy. Fifty-eight patients (16.5%) were alive and in the same functional classification, but 126 (35.8%) died within the first 5 years or were in a worse functional classification. Thirty-nine patients were doing excellently and 29 patients poorly 5 years after the operation. Of the surviving patients, 43% can do as much exercise as their peers, whereas 3% are incapable of exercise. Conclusions. To assure good functional long-term outcome in addition to survival, clinicians must exclude from selection for Fontan operation patients known to be at high risk for death or poor outcome.

Original languageEnglish (US)
Pages (from-to)469-496
Number of pages28
JournalCirculation
Volume85
Issue number2
StatePublished - Feb 1992

Fingerprint

Fontan Procedure
Survival
Tricuspid Atresia
Protein-Losing Enteropathies
Exercise
Hypoproteinemia
Reoperation
Pulmonary Artery
Survivors
Cardiac Arrhythmias

Keywords

  • Congenital heart disease
  • Modified Fontan operation
  • Single ventricle
  • Surgery
  • Univentricular heart

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Driscoll, D. J., Offord, K. P., Feldt, R. H., Schaff, H. V., Puga, F. J., & Danielson, G. K. (1992). Five- to fifteen-year follow-up after Fontan operation. Circulation, 85(2), 469-496.

Five- to fifteen-year follow-up after Fontan operation. / Driscoll, David J.; Offord, Kenneth P.; Feldt, Robert H.; Schaff, Hartzell V; Puga, Francisco J.; Danielson, Gordon K.

In: Circulation, Vol. 85, No. 2, 02.1992, p. 469-496.

Research output: Contribution to journalArticle

Driscoll, DJ, Offord, KP, Feldt, RH, Schaff, HV, Puga, FJ & Danielson, GK 1992, 'Five- to fifteen-year follow-up after Fontan operation', Circulation, vol. 85, no. 2, pp. 469-496.
Driscoll DJ, Offord KP, Feldt RH, Schaff HV, Puga FJ, Danielson GK. Five- to fifteen-year follow-up after Fontan operation. Circulation. 1992 Feb;85(2):469-496.
Driscoll, David J. ; Offord, Kenneth P. ; Feldt, Robert H. ; Schaff, Hartzell V ; Puga, Francisco J. ; Danielson, Gordon K. / Five- to fifteen-year follow-up after Fontan operation. In: Circulation. 1992 ; Vol. 85, No. 2. pp. 469-496.
@article{a130fd6be6a64675a6ae87790fb05d94,
title = "Five- to fifteen-year follow-up after Fontan operation",
abstract = "Background. The purpose of this study was to estimate survival and quality of outcome and assess factors associated with outcome for patients out 5 to 15 years from their Fontan operation. Methods and Results. We studied 352 patients who had the Fontan operation prior to 1985. The overall 1-, 5-, and 10-year survival was 77{\%}, 70{\%}, and 60{\%}, respectively. The following factors were significantly associated with lower survival: univentricular heart or complex congenital anomalies other than tricuspid atresia, early calendar year of operation, heterotaxia syndromes, early age at operation, increased pulmonary artery pressure, atrioventricular valve dysfunction, and higher (worse) New York Heart Association class; Reoperations were necessary for 103 of the 352 patients. At least 20{\%} of the survivors have or have had cardiac arrhythmias requiring antiarrhythmic medication or mechanical pacemaker insertion. Between 7{\%} and 10{\%} of the patients have had or had protein-losing enteropathy/hypoproteinemia. At 5 years postoperatively, 122 patients (34.7{\%}) were alive with a better New York Heart Association functional classification than preoperativeiy. Fifty-eight patients (16.5{\%}) were alive and in the same functional classification, but 126 (35.8{\%}) died within the first 5 years or were in a worse functional classification. Thirty-nine patients were doing excellently and 29 patients poorly 5 years after the operation. Of the surviving patients, 43{\%} can do as much exercise as their peers, whereas 3{\%} are incapable of exercise. Conclusions. To assure good functional long-term outcome in addition to survival, clinicians must exclude from selection for Fontan operation patients known to be at high risk for death or poor outcome.",
keywords = "Congenital heart disease, Modified Fontan operation, Single ventricle, Surgery, Univentricular heart",
author = "Driscoll, {David J.} and Offord, {Kenneth P.} and Feldt, {Robert H.} and Schaff, {Hartzell V} and Puga, {Francisco J.} and Danielson, {Gordon K.}",
year = "1992",
month = "2",
language = "English (US)",
volume = "85",
pages = "469--496",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Five- to fifteen-year follow-up after Fontan operation

AU - Driscoll, David J.

AU - Offord, Kenneth P.

AU - Feldt, Robert H.

AU - Schaff, Hartzell V

AU - Puga, Francisco J.

AU - Danielson, Gordon K.

PY - 1992/2

Y1 - 1992/2

N2 - Background. The purpose of this study was to estimate survival and quality of outcome and assess factors associated with outcome for patients out 5 to 15 years from their Fontan operation. Methods and Results. We studied 352 patients who had the Fontan operation prior to 1985. The overall 1-, 5-, and 10-year survival was 77%, 70%, and 60%, respectively. The following factors were significantly associated with lower survival: univentricular heart or complex congenital anomalies other than tricuspid atresia, early calendar year of operation, heterotaxia syndromes, early age at operation, increased pulmonary artery pressure, atrioventricular valve dysfunction, and higher (worse) New York Heart Association class; Reoperations were necessary for 103 of the 352 patients. At least 20% of the survivors have or have had cardiac arrhythmias requiring antiarrhythmic medication or mechanical pacemaker insertion. Between 7% and 10% of the patients have had or had protein-losing enteropathy/hypoproteinemia. At 5 years postoperatively, 122 patients (34.7%) were alive with a better New York Heart Association functional classification than preoperativeiy. Fifty-eight patients (16.5%) were alive and in the same functional classification, but 126 (35.8%) died within the first 5 years or were in a worse functional classification. Thirty-nine patients were doing excellently and 29 patients poorly 5 years after the operation. Of the surviving patients, 43% can do as much exercise as their peers, whereas 3% are incapable of exercise. Conclusions. To assure good functional long-term outcome in addition to survival, clinicians must exclude from selection for Fontan operation patients known to be at high risk for death or poor outcome.

AB - Background. The purpose of this study was to estimate survival and quality of outcome and assess factors associated with outcome for patients out 5 to 15 years from their Fontan operation. Methods and Results. We studied 352 patients who had the Fontan operation prior to 1985. The overall 1-, 5-, and 10-year survival was 77%, 70%, and 60%, respectively. The following factors were significantly associated with lower survival: univentricular heart or complex congenital anomalies other than tricuspid atresia, early calendar year of operation, heterotaxia syndromes, early age at operation, increased pulmonary artery pressure, atrioventricular valve dysfunction, and higher (worse) New York Heart Association class; Reoperations were necessary for 103 of the 352 patients. At least 20% of the survivors have or have had cardiac arrhythmias requiring antiarrhythmic medication or mechanical pacemaker insertion. Between 7% and 10% of the patients have had or had protein-losing enteropathy/hypoproteinemia. At 5 years postoperatively, 122 patients (34.7%) were alive with a better New York Heart Association functional classification than preoperativeiy. Fifty-eight patients (16.5%) were alive and in the same functional classification, but 126 (35.8%) died within the first 5 years or were in a worse functional classification. Thirty-nine patients were doing excellently and 29 patients poorly 5 years after the operation. Of the surviving patients, 43% can do as much exercise as their peers, whereas 3% are incapable of exercise. Conclusions. To assure good functional long-term outcome in addition to survival, clinicians must exclude from selection for Fontan operation patients known to be at high risk for death or poor outcome.

KW - Congenital heart disease

KW - Modified Fontan operation

KW - Single ventricle

KW - Surgery

KW - Univentricular heart

UR - http://www.scopus.com/inward/record.url?scp=0026569903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026569903&partnerID=8YFLogxK

M3 - Article

C2 - 1735145

AN - SCOPUS:0026569903

VL - 85

SP - 469

EP - 496

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 2

ER -